These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
85 related items for PubMed ID: 7513607
1. Effects of signalling transduction modulators on the transformed phenotypes in v-H-ras-transformed NIH 3T3 cells. Kuo ML, Kang JJ, Yang NC. Cancer Lett; 1993 Nov 01; 74(3):197-202. PubMed ID: 7513607 [Abstract] [Full Text] [Related]
3. Distinct signal transduction pathways for angiotensin-II in guinea pig gastric smooth muscle: differential blockade by indomethacin and tyrosine kinase inhibitors. Yang SG, Saifeddine M, Laniyonu A, Hollenberg MD. J Pharmacol Exp Ther; 1993 Feb 01; 264(2):958-66. PubMed ID: 8437135 [Abstract] [Full Text] [Related]
4. SCH 51344 inhibits ras transformation by a novel mechanism. Kumar CC, Prorock-Rogers C, Kelly J, Dong Z, Lin JJ, Armstrong L, Kung HF, Weber MJ, Afonso A. Cancer Res; 1995 Nov 01; 55(21):5106-17. PubMed ID: 7585559 [Abstract] [Full Text] [Related]
5. Tyrosine kinase regulates phospholipase D activation at a point downstream from protein kinase C in osteoblast-like cells. Kozawa O, Suzuki A, Oiso Y. J Cell Biochem; 1995 Feb 01; 57(2):251-5. PubMed ID: 7759561 [Abstract] [Full Text] [Related]
6. Cyclic AMP distinguishes between two functions of acidic FGF in a rat bladder carcinoma cell line. Boyer B, Thiery JP. J Cell Biol; 1993 Feb 01; 120(3):767-76. PubMed ID: 7678836 [Abstract] [Full Text] [Related]
7. Tyrosine kinase inhibitors and the contractile action of G-protein-linked vascular agonists. Laniyonu AA, Saifeddine M, Yang SG, Hollenberg MD. Can J Physiol Pharmacol; 1994 Sep 01; 72(9):1075-85. PubMed ID: 7842390 [Abstract] [Full Text] [Related]
13. Bradykinin B2 receptor-induced and inositol tetrakisphosphate-evoked Ca2+ entry is sensitive to a protein tyrosine phosphorylation inhibitor in ras-transformed NIH/3T3 fibroblasts. Hashii M, Nakashima S, Yokoyama S, Enomoto K, Minabe Y, Nozawa Y, Higashida H. Biochem J; 1996 Oct 15; 319 ( Pt 2)(Pt 2):649-56. PubMed ID: 8912707 [Abstract] [Full Text] [Related]
14. Effect of genistein on topoisomerase activity and on the growth of [Val 12]Ha-ras-transformed NIH 3T3 cells. Okura A, Arakawa H, Oka H, Yoshinari T, Monden Y. Biochem Biophys Res Commun; 1988 Nov 30; 157(1):183-9. PubMed ID: 2848517 [Abstract] [Full Text] [Related]
15. S-Adenosylmethionine decarboxylase gene expression is regulated by the cAMP signal transduction pathway in H-ras transformed fibrosarcoma cells capable of malignant progression. Hurta RA. J Cell Biochem Suppl; 2001 Nov 30; Suppl 36():209-21. PubMed ID: 11455586 [Abstract] [Full Text] [Related]
16. Multiple effects and stimulation of insulin secretion by the tyrosine kinase inhibitor genistein in normal mouse islets. Jonas JC, Plant TD, Gilon P, Detimary P, Nenquin M, Henquin JC. Br J Pharmacol; 1995 Feb 30; 114(4):872-80. PubMed ID: 7773549 [Abstract] [Full Text] [Related]
17. Suppression of invasion and MMP-9 expression in NIH 3T3 and v-H-Ras 3T3 fibroblasts by lovastatin through inhibition of ras isoprenylation. Wang IK, Lin-Shiau SY, Lin JK. Oncology; 2000 Sep 30; 59(3):245-54. PubMed ID: 11053993 [Abstract] [Full Text] [Related]
18. Inhibition of phospholipase D of human platelets by protein tyrosine kinase inhibitors. Martinson EA, Scheible S, Presek P. Cell Mol Biol (Noisy-le-grand); 1994 Jul 30; 40(5):627-34. PubMed ID: 7526916 [Abstract] [Full Text] [Related]